Marsh Linda 4

4 · Apollo Medical Holdings, Inc. · Filed Mar 13, 2023

Form 4

Period: 2020-03-04

Director

Transactions

Exercise/Conversion
Common Stock
2023-03-09$10.00/sh+62,500$625,000→ 62,500 total
Award
Stock Option (right to buy)
2020-03-04+62,500→ 62,500 total
Exercise: $10.00Exp: 2023-04-05→ Common Stock (62,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2023-03-09−62,500→ 0 total
Exercise: $10.00Exp: 2023-04-05→ Common Stock (62,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-03-04−62,500→ 0 total
Exercise: $10.00Exp: 2020-04-05→ Common Stock (62,500 underlying)

Holdings

Footnotes (3)

[F1]These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
[F2]The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.
[F3]The stock options were granted on March 4, 2020 and vested and became exercisable on the date of the grant.

Documents

1 file